Cardiac Function Better in HFrEF With Novel Agent

ACC Conference Reporter

AHA 2015 | ORLANDO, FL — The novel agent omecamtiv mecarbil might improve cardiac contraction characteristics in heart failure with reduced ejection fraction (HFrEF), an early-phase study suggested. Read More >>>

Keywords: AHA Annual Scientific Sessions


< Back to Listings